tradingkey.logo

CytomX Therapeutics Inc

CTMX
4.400USD
+0.200+4.76%
Close 12/24, 13:00ETQuotes delayed by 15 min
726.31MMarket Cap
14.94P/E TTM

CytomX Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
138.10M
36.45%
EPS(YoY)
0.38
4995.20%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its total revenue reached 138.10M, with a year-on-year change of 36.45%.

What is the Earnings Per Share (EPS) of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.377, with a year-on-year change of 4995.20%.

What is the net income of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its net income was 31.87M, with a year-on-year change of 5700.88%.

What is the net margin of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its net profit margin was 23.08%, with a year-on-year change of 4204.78%.

What is the gross margin of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.

What is the debt-to-asset ratio of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.

What is the Return on Assets (ROA) of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 19.77%, with a year-on-year change of 8139.80%.

What is the operating profit of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its operating profit was 25.00M, with a year-on-year change of 485.49%.

What are the current assets of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its current assets were 107.31M, with a year-on-year change of -41.34%.

What are the total assets of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its total assets of CytomX Therapeutics Inc were 120.53M, with a year-on-year change of -40.27%.

What are the total liabilities of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its total liabilities of CytomX Therapeutics Inc were 120.99M, with a year-on-year change of -51.46%.

What is the total equity of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its total equity of CytomX Therapeutics Inc was -456.00K, with a year-on-year change of 99.04%.

What is the net operating income of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its net operating income of CytomX Therapeutics Inc was 31.87M, with a year-on-year change of 5700.88%.

What is the net investment of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its net investment of CytomX Therapeutics Inc was 99.70M, with a year-on-year change of 166.17%.

What is the net financing of CytomX Therapeutics Inc?

According to CytomX Therapeutics Inc's FY2024 earnings report, its net financing of CytomX Therapeutics Inc was 7.52M, with a year-on-year change of -75.12%.
KeyAI